Literature DB >> 25251737

Positive and negative mood in men with advanced prostate cancer undergoing androgen deprivation therapy: considering the role of social support and stress.

Catherine Benedict1, Jason R Dahn2, Michael H Antoni3,4, Lara Traeger5, Bruce Kava6, Natalie Bustillo3, Eric S Zhou7, Frank J Penedo8.   

Abstract

UNLABELLED: Advanced prostate cancer patients often undergo androgen deprivation therapy (ADT). Advanced disease and adverse ADT side effects are often debilitating and negatively impact mood. Social support has been shown to mitigate detrimental effects of stress on mood.
OBJECTIVE: This study sought to characterize positive and negative mood in this select patient population and determine whether social support moderated relations between stress and mood.
METHODS: Participants (N = 80) completed the Interpersonal Support Evaluation List, Perceived Stress Scale, and Derogatis Affect Balance Scale at a single time point. Hierarchical regression models evaluated relations among social support, stress, and mood controlling for relevant covariates. Standard moderation analyses were performed.
RESULTS: Participants reported higher levels of negative and positive mood compared with published means of localized prostate cancer patients. Overall, mood was more positive than negative. Stress levels were comparable to cancer populations with recurrent disease. Moderated regression analyses showed that social support partially buffered the effects of stress on positive mood; men with high stress and low support reported the lowest levels of positive mood. The model with negative mood as the dependent measure did not support moderation; that is, the relationship between stress and negative mood did not differ by level of social support.
CONCLUSION: Among individuals living with advanced prostate cancer, social support may be an important factor that sustains positive mood in the presence of stress. Future work should examine the extent to which social support prospectively impacts health-related quality of life by promoting positive mood. Limitations include cross-sectional design, which precludes causal inferences.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  affective aspects; cancer; mental health; oncology; psychological stress; social support

Mesh:

Substances:

Year:  2014        PMID: 25251737     DOI: 10.1002/pon.3681

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  5 in total

1.  The Role of Inflammation in the Pain, Fatigue, and Sleep Disturbance Symptom Cluster in Advanced Cancer.

Authors:  Kristine L Kwekkeboom; Lauren Tostrud; Erin Costanzo; Christopher L Coe; Ronald C Serlin; Sandra E Ward; Yingzi Zhang
Journal:  J Pain Symptom Manage       Date:  2018-01-31       Impact factor: 3.612

2.  Caregiving and social support for gay and bisexual men with prostate cancer.

Authors:  Benjamin D Capistrant; Beatriz Torres; Enyinnaya Merengwa; William G West; Darryl Mitteldorf; B R Simon Rosser
Journal:  Psychooncology       Date:  2016-09-15       Impact factor: 3.894

3.  Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer.

Authors:  Jessica Miceli; David Geller; Allan Tsung; Carol Lynn Hecht; Yisi Wang; Ritambhara Pathak; Hannah Cheng; Wallis Marsh; Michael Antoni; Frank Penedo; Lora Burke; Kathleen Ell; Shutian Shen; Jennifer Steel
Journal:  Psychooncology       Date:  2019-06-04       Impact factor: 3.894

4.  A little help from my friends: social support in palliative rehabilitation.

Authors:  N A Rutkowski; S Lebel; K Richardson; B Mutsaers; M Chasen; A Feldstain
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

5.  Improvement in quality of life and psychological well-being associated with a culturally based psychosocial intervention for Chinese American breast cancer survivors.

Authors:  Qian Lu; Lingjun Chen; Lilian J Shin; Carol Wang; Lenna Dawkins-Moultin; Qiao Chu; Alice Loh; Lucy Young; Carol Wang
Journal:  Support Care Cancer       Date:  2021-01-22       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.